首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   234466篇
  免费   20408篇
  国内免费   5760篇
耳鼻咽喉   3437篇
儿科学   4597篇
妇产科学   4026篇
基础医学   19337篇
口腔科学   7621篇
临床医学   22647篇
内科学   23312篇
皮肤病学   3870篇
神经病学   11565篇
特种医学   7009篇
外国民族医学   12篇
外科学   21821篇
综合类   35452篇
现状与发展   11篇
一般理论   30篇
预防医学   31071篇
眼科学   2191篇
药学   24058篇
  343篇
中国医学   28472篇
肿瘤学   9752篇
  2024年   620篇
  2023年   4552篇
  2022年   7267篇
  2021年   11772篇
  2020年   11251篇
  2019年   12545篇
  2018年   11170篇
  2017年   9664篇
  2016年   8742篇
  2015年   8194篇
  2014年   16036篇
  2013年   16606篇
  2012年   14142篇
  2011年   15300篇
  2010年   12180篇
  2009年   10710篇
  2008年   10072篇
  2007年   9951篇
  2006年   8577篇
  2005年   7170篇
  2004年   5973篇
  2003年   5313篇
  2002年   4097篇
  2001年   3457篇
  2000年   3043篇
  1999年   2567篇
  1998年   2083篇
  1997年   1874篇
  1996年   1569篇
  1995年   1460篇
  1994年   1352篇
  1993年   1192篇
  1992年   1140篇
  1991年   995篇
  1990年   857篇
  1989年   833篇
  1988年   786篇
  1987年   701篇
  1986年   619篇
  1985年   1908篇
  1984年   2158篇
  1983年   1358篇
  1982年   1771篇
  1981年   1245篇
  1980年   1074篇
  1979年   955篇
  1978年   769篇
  1977年   589篇
  1976年   733篇
  1975年   493篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
PurposeTo compare morphological imaging features and CT texture histogram parameters between grade 3 pancreatic neuroendocrine tumors (G3-NET) and neuroendocrine carcinomas (NEC).Materials and methodsPatients with pathologically proven G3-NET and NEC, according to the 2017 World Health Organization classification who had CT and MRI examinations between 2006-2017 were retrospectively included. CT and MRI examinations were reviewed by two radiologists in consensus and analyzed with respect to tumor size, enhancement patterns, hemorrhagic content, liver metastases and lymphadenopathies. Texture histogram analysis of tumors was performed on arterial and portal phase CT images. images. Morphological imaging features and CT texture histogram parameters of G3-NETs and NECs were compared.ResultsThirty-seven patients (21 men, 16 women; mean age, 56 ± 13 [SD] years [range: 28-82 years]) with 37 tumors (mean diameter, 60 ± 46 [SD] mm) were included (CT available for all, MRI for 16/37, 43%). Twenty-three patients (23/37; 62%) had NEC and 14 patients (14/37; 38%) had G3-NET. NECs were larger than G3-NETs (mean, 70 ± 51 [SD] mm [range: 18 - 196 mm] vs. 42 ± 24 [SD] mm [range: 8 - 94 mm], respectively; P = 0.039), with more tumor necrosis (75% vs. 33%, respectively; P = 0.030) and lower attenuation on precontrast (30 ± 4 [SD] HU [range: 25-39 HU] vs. 37 ± 6 [SD] [range: 25-45 HU], respectively; P = 0.002) and on portal venous phase CT images (75 ± 18 [SD] HU [range: 43 - 108 HU] vs. 92 ± 19 [SD] HU [range: 46 - 117 HU], respectively; P = 0.014). Hemorrhagic content on MRI was only observed in NEC (P = 0.007). The mean ADC value was lower in NEC ([1.1 ± 0.1 (SD)] × 10−3 mm2/s [range: (0.91 - 1.3) × 10−3 mm2/s] vs. [1.4 ± 0.2 (SD)] × 10−3 mm2/s [range: (1.1 - 1.6) × 10−3 mm2/s]; P = 0.005). CT histogram analysis showed that NEC were more heterogeneous on portal venous phase images (Entropy-0: 4.7 ± 0.2 [SD] [range: 4.2-5.1] vs. 4.5 ± 0.4 [SD] [range: 3.7-4.9]; P = 0.023).ConclusionPancreatic NECs are larger, more frequently hypoattenuating and more heterogeneous with hemorrhagic content than G3-NET on CT and MRI.  相似文献   
92.
目的 评价中老年人社会资本量表的信效度,探索其在不同健康状况的中老年人群间的区分度。方法 针对已编制的中老年人社会资本量表,采用多阶段分层随机抽样方法,在四川省成都市及泸州市共抽取1 367名50岁及以上中老年居民进行问卷调查。运用Cronbach’s α系数、Pearson相关系数、t检验、探索性因子分析等方法评价量表的信度和效度。结果 1 367名中老年调查对象的社会资本量表总Cronbach’s α系数为0.67,各维度条目与总分的相关系数在0.30~0.79之间,具有良好的信度;探索性因子分析表明,14个条目提取出5个特征根大于1的因子,累积方差贡献率为68.84%;现患慢性疾病的中老年病例组人群的个人社会资本得分、家庭社会资本得分、社团社会资本得分、社区社会资本得分及社会资本总得分均低于未患病的对照人群组,宏观社会资本得分高于对照人群组,且差异均有统计学意义 (均 P<0.01),提示该量表具有较好的区分度。结论 中老年人社会资本量表具有较好的信度和效度,且对不同健康状况的50岁及以上中老年人中有较好的区分度。  相似文献   
93.
妊娠期甲状腺癌的诊治是目前甲状腺疾病诊治的热点和难点问题之一。妊娠期发现甲状腺癌对临床医生和孕妇都是一个极大的挑战,应通过多学科协作,尽快明确诊断,全面、合理的评估孕妇和胎儿的情况,选择最合适的治疗和随诊方式,避免对孕妇和胎儿产生副反应,维持正常孕期,获得最佳的治疗效果。  相似文献   
94.
95.
Responsive feeding (RF) has been recognized as necessary to prevent all forms of malnutrition including stunting and childhood obesity. Specific RF guidelines have been developed, but it is unclear how RF behaviours can be monitored systematically. Therefore, developing valid and reliable abbreviated and pragmatic RF scales is an important global priority. This is challenging, as RF is a construct with multiple dimensions including recognizing and responding to hunger and satiety cues, providing a nurturing environment during feeding episodes, and understanding how feeding needs evolve as a function of the developmental stage of the young child. Further, RF is embedded within the responsive parenting framework that in addition to RF includes sleep, soothing and play routines and the interconnections between them. A recent pioneer study conducted in a rural area of Cambodia validated an 8‐item RF scale through direct feeding observations of 6‐ to 23‐month‐old infants at home, as part of two cross‐sectional surveys conducted before and after a complementary feeding intervention. It is important for similar research to be conducted elsewhere to find out if it is possible or not to develop a core RF scale that is valid and reliable and that has adequate specificity and sensitivity for application in community studies and population surveys globally. As highlighted in this article, different definitions of RF have been used in the field; thus, it is important to reach consensus on a single definition to help move this research area forward.  相似文献   
96.
《中国现代医生》2020,58(4):84-86+90
目的评价西药联合穴位贴敷中西医结合治疗复治肺结核的临床疗效。方法选择本院2017年1月~2018年1月收治的60例复治肺结核患者进行分组研究,全部患者根据治疗方法不同随机分为两组,每组各30例。两组均采取西药进行治疗,采用2HRZE/6HRZ标准化疗方案,实验组同时联合穴位贴敷中西医结合进行治疗,治疗后对比分析两组病灶吸收情况及两组临床症状改善情况。结果实验组病灶恶化9例,其病灶显著吸收率达50.0%,总有效率达70.0%,对照组病灶恶化6例,不变5例,其病灶显著吸收率达33.3%,总有效率达63.3%,两组病灶吸收总有效率组间比较,差异具有显著性(P0.05);实验组的疗效指数治疗6个月后显著高于对照组,组间比较,差异具有显著性(P0.05)。结论西药联合穴位贴敷中西医结合治疗复治肺结核疗效确切,可以显著促进病灶吸收,改善临床症状,安全性好,且还可以扶助人体正气,提高机体免疫力,调节全身状态,以达到治疗目的,是治疗复治肺结核的有效方法之一,值得临床广泛推广和应用。  相似文献   
97.
PurposeFew investigations have examined the production of single restorations using intraoral scanners (IOS). Data on full-arch scans are rare, and data regarding torsion within the entire arch are very sparsely reported. Therefore, the aim of this study was to examine the deviations of torsion and linear distances in full-arch scans of three IOS based on different scanning principles.MethodsA cobalt-chrome-molybdenum alloy master model (CCMM) with four hemispheres was fabricated by laser sintering. The CCMM was digitized using a laboratory scanner (ATOS-Core/GOM) and scanned with three IOS (Omnicam/Sirona(OC); True Definition/3M(TD); TriosII/Cara-Version/Kulzer(TR)). All scan data were exported in a standard STL-file format and were analyzed with GOM Inspect software (V7.5/GOM). Torsion between the right and left side of the arch and linear accuracy (trueness and precision) were evaluated. After normality was confirmed, all data were subjected to parametric statistical analyses.ResultsThe torsion ranged from 0.07 ± 0.03°(OC) to 0.29 ± 0.14°(TD). Pairwise comparisons showed significant differences between the OC and TD scanners and between the TR and TD scanners. The linear distances ranged from 6 ± 5 μm(OC) to 298 ± 317 μm(TD). Significant differences were observed among all investigated IOS (p = 0.05).ConclusionsAlthough the highest torsion was observed for the TD scanner, it is still not clear whether the differences between the IOS are related to the scanning principle or to the scanning algorithm. Due to the high clinical relevance of full-arch restorations, future studies should consider torsion. Regarding linear accuracy, no general difference related to the scanning principles of the IOSs was observed.  相似文献   
98.
99.
刘煜  郭军  晏斌  刘胜京  郭俊  赵丰  王福 《世界中医药》2020,15(8):1192-1195
男性不育症中,精液分析多种参数异常且无法找到明确病因的称为特发性男性不育症,其发病率不断提高,给国内甚至全球范围内家庭带来精神及经济负担。由于病因不明确,目前现代医学尚无有效治疗方法。传统中医药通过辨证论治在治疗特发性男性不育症时具有优势,郭军教授认为该病以肾脾两虚为本,为体内湿热形成奠定基础,患者久病无子嗣,肝气不畅则郁结,气血津液运行不通则夹血瘀湿热等有形实邪,另外怪病多痰。故对于特发性男性不育症,治法注重补泻兼施,扶正祛邪,补益脾肾为主,对于湿热、痰湿、瘀血则清热祛湿化痰,活血化瘀等,并举验案1例。  相似文献   
100.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号